The treatment of childhood Hodgkin lymphoma: Improved survival in a developing country

Acta Oncologica

Volumn 48, Issue 1, 2009, Pages 44-51

  Büyükpamukču, Münevver ^a   Varan, Ali ^a   Akyüz, Canan ^a   Atahan, Lale ^a   Özyar, Enis ^a   Kale, Gülsev ^a   Köksal, Yavuz ^a   Kutluk, Tezer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILD CARE; CHILDHOOD CANCER; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 58149091609     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802310991     Document Type: Article

References (24)

1. th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 695-721.
2. Çavdar AO, Taçoy A, Babacan E, Gözdaşoǧ lu S, Arcasoy A, Topuz U, et al. Hodgkin's disease in Turkish children: A clinical and histopathological analysis. J Natl Cancer Inst 1977;58:479-81.
3. Ertem U, Duru F, Daǧdemir A, Taçyildiz N, Pamir A, Akçayöz A, et al. Hodgkin's disease in 82 Turkish children diagnosed over a 10-year period: Epidemiological, clinical, and histopathologic features and prognosis with prolonged chemotherapy. Pediatr Hematol Oncol 1997;14:359-66.
4. Büyükpamukçu M, Atahan L, .Ç aǧlar M, Kutluk T, Akyüz C, Hazar V. Hodgkin's disease in Turkish children: Clinical characteristics and treatment results of 210 patients. Pediatr Hematol Oncol 1999;16:119-29.
5. Gözdaşoǧlu S, .Ü nal E, Ertem M, Yavuz G, Pamir A, Taçyildiz N, et al. Modified OPPA/COPP chemotherapy and involved-field radiation therapy for the treatment of Hodgkin's disease in Turkish children. Turk J Haematol 2001;18:47-52.
6. .Ç avdar AO, Gözdaşoǧlu S, Yavuz G, Unal E, Pamir A, Taçyildiz N, et al. Characteristics of early type-I pattern (0-6 years) Hodgkin's disease in Turkish children. Turk J Haematol 2002;19:55-62.
7. Karimi M, Yarmohammadi H, Ghavanini AA, Kumar PV. Epidemiological surveillance of pediatric Hodgkin's disease in southern Iran. Med Sci Monit 2002;8:CR572-5.
8. Oguz A, Karadeniz C, Okur FV, .Ç itak EC, Pinarli FG, Bora H, et al. Prognostic factors and treatment outcome in childhood Hodgkin disease. Pediatr Blood Cancer 2005;45:670-5.
9. Hjalgrim H, Smedby KE, Rostgaard K, Molin D, Hamilton-Dutoit S, Chang ET, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin Lymphoma. Cancer Res 2007;67:2382-8.
10. Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, et al. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 2003;21:2026-33.
11. Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, et al. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 2004;22:4541-50.
12. Hakvoort-Cammel FGAJ, Buitendijk S, van den Heuvel-Eibrink M, Hahlen K. Treatment of pediatric Hodgkin disease avoiding radiotherapy: Excellent outcome with the Rotterdam-HD-84-protocol. Pediatr Blood Cancer 2004;43:8-16.
13. Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, et al. POG 8625: Randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with stages I, IIA, IIIA1 Hodgkin disease. J Pediatr Hematol Oncol 2006;28:362-8.
14. Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcon PA, Chauvenet AR. A report from the Children's Oncology Group. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin's disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study. Pediatr Blood Cancer 2006;46:198-202.
15. Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z. Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): Report from the Automated Cancer Information System project. Eur J Cancer 2006;42:2037-49.
16. Nachman JB, Sposto R, Herzog P, Gilchrist GS,Wolden SL, Thomson J et al for the Children's Cancer Group. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002;20:3765-71.
17. Capra M, Hewitt M, Radford M, Hayward J, Weston CL, Machin D. On behalf of Children's Cancer and Leukaemia Group (formerly UKCCSG). Long-term outcome in children with Hodgkin's lymphoma: The United Kingdom Children's Cancer Study Group HD82 trial. Eur J Cancer 2007;43:1171-9.
18. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630-6.
19. Barista I, Varan A, Ozyar E. Bimodal age distribution in Hodgkin's disease and nasopharyngeal carcinoma. Med Hypotheses 2007;68:1421.
20. Gulley ML, Eagan PA, Quintanilla-Martinez L, Picado AL, Smir BN, Childs C, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994;83:1595-602.
21. Stoneham S, Ashley S, Pinkerton R, Hewitt M, Wallace WHB, Shankar AG. On behalf of Children's Cancer and Leukaemia Group (formerly UKCCSG). Hodgkin's lymphoma in children aged 5 years or less-the United Kingdom experience. Eur J Cancer 2007;43:1415-21.
22. Hsu SC, Metzger ML, Hudson MM, Pedrosa F, Lins M, Pedrosa M, et al. Comparison of treatment outcomes of childhood Hodgkin's lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer 2007;49:139-44.
23. Spitz MR, Sider JG, Cole Johnson C, Butler JJ, Pollack ES, Newell GR. Ethnic patterns of Hodgkin's disease incidence among children and adolsescents in the United States, 1973-82. J Natl Cancer Inst 1986;76:235-9.
24. Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, et al. Hodgkin's disease in Indian children: Outcome with chemotherapy alone. Pediatr Blood Cancer 2006;46:26-34.